| Session 5B - Health Services and
Research: Interdisciplinary Perspectives
Chair: Leeat Granek
Placebo Controls: Epistemic Virtue or Vice?
Jeremy
Howick
Department of Philosophy, Logic, and Scientific Method, London School
of Economics and Political Science,
London, United Kingdom
Randomized, placebo-controlled trials are often considered
the gold standard for medical research. However, placebo controls have
been challenged on ethical and practical grounds. I argue that, in addition
to cases where placebo controls may be unethical or impractical, there
are cases where placebo controls are impossible to construct. In particular,
treatments whose characteristic effects are not readily distinguished
from their incidental effects do not lend themselves to being imitated
by placebos.
Comparing the effectiveness of these treatments to placebos
leads to misguided accusations of methodological errors such as unblinding,
and false negative results. If I am correct, then for at least a certain
class of treatments, requiring placebo controls is an epistemological
vice. Treatments that are impossible to test in conventional placebo-controlled
trials include surgery, psychotherapy, acupuncture, and exercise.
I critically
evaluate attempts to solve the problem with placebo controls in studies
of complex treatments (Kirsch 2005; Paterson and Dieppe 2005), and conclude
that they are all lacking. I then argue for a method that takes the strengths
of the attempted methods into account while avoiding their problems.
I suggest replacing placebo-controlled trials of certain treatments with
comparative trials. A comparative trial compares one treatment against
another treatment instead of a placebo.
Is Informed Consent an Adequate
and Necessary Protection for Research Subjects?
Gloria
Likupe
Faculty of Health and Social Care, University of Hull, Cottingham Road,
HU6 7RXUnited Kingdom
The principle of informed consent was born out outrage
at the atrocities committed by German physicians and scientists under
the Hitler regime After the Second World War, the war crimes tribunal
convicted several of the Nazi Doctors and produced what has since become
to be known as the Nuremberg Code, widely regarded as the first international
code of human experimentation ethics.
Later the international codes of ethics such as the Declaration of Helsinki
and the International Ethical guidelines adopted by the Council for International
Organizations of Medical Sciences outline and reassert the primacy of
informed consent. The declaration of Helsinki makes it clear that medical
progress is based on research which ultimately must rest on experimentation
on the patient. The declaration also makes it clear that informed consent
is central to research on human subjects. While the situation is clear
in non therapeutic research, it is not so in therapeutic research where
clearly there are some populations such as in emergency situations
from which it will not be possible to obtain informed consent. Some
have argued that even in situations where researchers are dealing with
competent adults, research subjects systematically misinterpret the risk/benefit
ratio of participating in research because they fail to understand the
underlying scientific methodology. In such cases what the participant
is actually consenting to is substantially different to what they think
they are consenting to and therefore informed consent is frustrated.
This paper will discuss whether informed consent is an adequate
protection for research subjects and whether it is necessary.
Download Conference Paper -  |